Clindamycin Injection USP in 5% Dextrose
CGMP Deviations
Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.
Defective Container: Out of specification for weight due to a slow leakage at the 12-month stability timepoint.
Cause type: Packaging defect
Failed child-resistant closures, leaks, cracked containers, or a defective delivery device. Packaging failures risk accidental exposure (especially to children) or product contamination. All packaging defect recalls.
Clindamycin Phosphate, Topical Solution USP, 1%, 60 mL, Rx Only, Manufactured for and Distributed by: Marlex Pharmaceuticals, Inc., New Castle, DE 19720, NDC 10135-0691-61
Compare with the code on your package — it is the most precise check available.
Drug: Clindamycin Category: Antibiotic
Low risk, still worth a check. Class III means the product is unlikely to cause harm but breaks an FDA rule (often labeling). If your lot matches, your pharmacy will normally swap it; there is no need for alarm.
CGMP Deviations
CGMP Deviations
CGMP Deviations
CGMP Deviations
CGMP Deviations
Defective Container: Out of specification for weight due to a slow leakage at the 12-month stability timepoint.
Defective Container: slow leakage under the cap
Free recall alerts
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.